Literature DB >> 18293281

Assessment of prognosis of cirrhosis.

François Durand1, Dominique Valla.   

Abstract

Once patients with cirrhosis experience decompensation, early mortality risk increases sharply. Liver transplantation has transformed the prognosis of decompensated cirrhosis. Child-Pugh score has been the reference for many years for assessing the prognosis of cirrhosis. However, Child-Pugh score has important limitations among which is subjective interpretation of some of its variables, making it difficult to categorize patients according to their own disease severity. The model for end-stage liver disease (MELD) score, which was originally designed for assessing the prognosis of cirrhotic patients undergoing transjugular intrahepatic portosystemic shunt (TIPS), is a continuous score relying on three objective variables. Along with TIPS, MELD score proved to be a robust marker of early mortality across a wide spectrum of causes of cirrhosis, even though 10 to 20% of patients are still misclassified. MELD is especially useful for prioritizing candidates for transplantation according to a "sickest first" policy. However, MELD is not a universal prognostic marker of cirrhosis and several MELD exceptions require more specific approaches.

Entities:  

Mesh:

Year:  2008        PMID: 18293281     DOI: 10.1055/s-2008-1040325

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  76 in total

Review 1.  Prioritization for liver transplantation.

Authors:  Evangelos Cholongitas; Giacomo Germani; Andrew K Burroughs
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-02       Impact factor: 46.802

2.  Management of liver cirrhosis between primary care and specialists.

Authors:  Ignazio Grattagliano; Enzo Ubaldi; Leonilde Bonfrate; Piero Portincasa
Journal:  World J Gastroenterol       Date:  2011-05-14       Impact factor: 5.742

3.  A Dynamic Definition of Acute Kidney Injury Does not Improve Prognosis Assessment in Acutely Decompensated Patients with Cirrhosis.

Authors:  Sebastián Marciano; Ezequiel Mauro; Melisa Dirchwolf; María Emilia Debernardi; Diego Giunta; Vanina Pagotto; Liliana Rojas; Adrián Gadano
Journal:  J Clin Exp Hepatol       Date:  2017-03-16

4.  Chronic liver disease impairs bacterial clearance in a human model of induced bacteremia.

Authors:  Alix Ashare; Clark Stanford; Patricia Hancock; Donna Stark; Kathleen Lilli; Emily Birrer; Amanda Nymon; Kevin C Doerschug; Gary W Hunninghake
Journal:  Clin Transl Sci       Date:  2009-06       Impact factor: 4.689

5.  Cystatin C: a predictor of hepatorenal syndrome in patients with liver cirrhosis.

Authors:  Mohammed A Sharawey; Eglal M Shawky; Lamia H Ali; Ahmed Ali Mohammed; Hatem A Hassan; Yasser M Fouad
Journal:  Hepatol Int       Date:  2011-03-12       Impact factor: 6.047

6.  Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study.

Authors:  Matteo Bassetti; Maddalena Peghin; Alessia Carnelutti; Elda Righi; Maria Merelli; Filippo Ansaldi; Cecilia Trucchi; Cristiano Alicino; Assunta Sartor; Pierluigi Toniutto; Joost Wauters; Wim Laleman; Carlo Tascini; Francesco Menichetti; Roberto Luzzati; Pierluigi Brugnaro; Alessio Mesini; Stefania Raviolo; Francesco G De Rosa; Leonel Lagunes; Jordi Rello; George Dimopoulos; Arnaldo L Colombo; Marcio Nucci; Antonio Vena; Emilio Bouza; Patricia Muñoz; Mario Tumbarello; Raffaella Losito; Ignacio Martin-Loeches; Claudio Viscoli
Journal:  Intensive Care Med       Date:  2017-03-07       Impact factor: 17.440

7.  Application of transcutaneous ultrasonography for the diagnosis of muscle mass loss in patients with liver cirrhosis.

Authors:  Kazufumi Kobayashi; Hitoshi Maruyama; Soichiro Kiyono; Sadahisa Ogasawara; Eiichiro Suzuki; Yoshihiko Ooka; Tetsuhiro Chiba; Naoya Kato; Tadashi Yamaguchi
Journal:  J Gastroenterol       Date:  2017-08-18       Impact factor: 7.527

Review 8.  Model for end-stage liver disease: end of the first decade.

Authors:  Sumeet K Asrani; W Ray Kim
Journal:  Clin Liver Dis       Date:  2011-10-01       Impact factor: 6.126

Review 9.  Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.

Authors:  Sith Siramolpiwat
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

10.  Value of MELD and MELD-based indices in surgical risk evaluation of cirrhotic patients: retrospective analysis of 190 cases.

Authors:  Beatriz P Costa; F Castro Sousa; Marco Serôdio; César Carvalho
Journal:  World J Surg       Date:  2009-08       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.